ArticleAmerican journal of cancer research2018

MiR-382 targets GOLM1 to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.

Shukun Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.